Get started
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJIEE

EYEBRIGHT MEDICAL TECHNOLOGY (BEIJI

98.58CNYD
+0.20+0.20%
As of today at 07:00 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

688050 fundamentals

Key facts

Market capitalization‪18.65 B‬CNY
Dividend yield (indicated)0.28%
Price to earnings Ratio (TTM)—
Basic EPS (TTM)12.68CNY
Founded2010
Employees (FY)—
CEOJiang Bing Xie
Websiteebmedical.com
About

Eyebright Medical Technology (Beijing) Co., Ltd. engages in the research and development, production, sales and related services of ophthalmic medical equipment and devices. It offers retail pharmaceuticals, technology development, technology transfer, technical consulting, and technical services of disinfection products, sanitary products, and contact lens care products. The company was founded by Zhao Wang and Jiang Bing Xie on April 21, 2010 and is headquartered in Beijing, China.

Ownership
‪‪189.29 M‬‬
Free Float shares
‪‪125.67 M‬‬ (66.39%)
Closely held shares
‪‪63.62 M‬‬ (33.61%)
Free Float shares
‪‪125.67 M‬‬ (66.39%)
Closely held shares
‪‪63.62 M‬‬ (33.61%)
Capital structure
Market cap
‪‪18.65 B‬‬
Enterprise value
‪‪18.65 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪18.65 B‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
‪0.00‬
‪5.00‬
‪10.00‬
‪15.00‬
‪20.00‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪15.00‬
‪30.00‬
‪45.00‬
‪60.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪15%‬
‪20%‬
‪25%‬
‪30%‬
‪35%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪100.00 M‬‬
‪‪200.00 M‬‬
‪‪300.00 M‬‬
‪‪400.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−340.00 M‬‬
‪‪−170.00 M‬‬
‪0.00‬
‪‪170.00 M‬‬
‪‪340.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−340.00 M‬‬
‪‪−170.00 M‬‬
‪0.00‬
‪‪170.00 M‬‬
‪‪340.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Artificial Lens
Orthokeratology Lenses
Contact Lenses
Other Myopia Prevention and Control
Other Surgical Products
Other Vision Care
Other Income
By country
Period: 2024
China
Overseas

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪110.00 M‬‬
‪‪220.00 M‬‬
‪‪330.00 M‬‬
‪‪440.00 M‬‬
Actual
Estimate
Earnings
Next:Apr 17, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪0.20‬
‪0.40‬
‪0.60‬
‪0.80‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
0.00%
Payout ratio (TTM)
Dividend yield TTM
0.16%
Last payment
0.49
Last ex-date
Jun 5, 2024
Dividend history
‪0.15%‬
‪0.17%‬
‪0.19%‬
‪0.21%‬
‪0.23%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.08‬
‪0.16‬
‪0.24‬
‪0.32‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−250.00 M‬‬
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.